enzon pharmaceuticals inc
(ENZN:Consolidated Issue listed on NASDAQ Capital Market)
Thomas F. Deuel M.D.
Former Director and Member of Compensation Committee, Enzon Pharmaceuticals Inc.
|Age||Total Calculated Compensation||This person is connected to 32 board members in 2 different organizations across 4 different industries.|
See Board Relationships
Dr. Thomas J. Deuel, Tom, serves as the Director of the Division of Molecular Oncology. Dr. Deuel also serves as the Director of Department of Molecular and Experimental Medicine and Director of the Vascular Biology Affinity Group at The Scripps Research Institute since February 2002. Dr. Deuel's areas of expertise include molecular biology, biochemistry, hematology, cardiology and oncology. He serves as the President of the Edward R. Mallinckrodt Foundation, St. Louis, ...
20 Kingsbridge RoadPhone: 732-980-4500
Piscataway, New Jersey 08854
Board Members Memberships*There is no Board Members Memberships data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Howard W. Robin||Chief Executive Officer, President and Director|
|Judith Greciet Ph.D., Pharmacy||Chief Executive Officer, Director and Member of Corporate Development Committee|
|William J. Polvino M.D.||Chief Executive Officer and President|
Veloxis Pharmaceuticals A/S
|Daniel J. Abdun-Nabi||Chief Executive Officer, President, Director, Member of Strategic Operations Committee and Member of Pricing Committee|
Emergent BioSolutions, Inc.
|Paul C. Grint M.D.||Chief Executive Officer, President and Director|
Regulus Therapeutics Inc.
|--||Compensation as of Fiscal Year 2014.|